Published Date: 22 Apr 2023
A recent study found that preprints provide spin in addition to new science. F. remarks made by Perry Wilson.
Read Full NewsThe director of the Banner Sun Health Research Institute discussed a variety of meaningful Alzheimer disease research presented at the 2024 Clinical Trials on Alzheimer's Disease Conference (CTAD).
Elizabeth Gerard, MD, an epileptologist at Northwestern Medicine, provided clinical insights on a new consortium, GEAN, which aims to expand genetic testing and define adult phenotypes for rare genetic epilepsies across North America.
Angela Lek, PhD, chief research officer of the Muscular Dystrophy Association, discusses the FDA approval of intrathecal onasemnogene abeparvovec (Itvisma; Novartis) and what it means for SMA treatment across older pediatric and adult populations.
Dietary Diversity With Dairy, Fruit, Grains Linked to Lower Gout Risk
GLPG3667 Meets Primary Endpoint in Dermatomyositis, Misses in SLE Phase 3 Trials
taVNS Reduces Pain, Improves Mood in Fibromyalgia Patients
Metal Exposure Levels May Explain Cardiovascular-Kidney-Metabolic Stages
1.
Francis Collins reveals that he was diagnosed with "aggressive" prostate cancer.
2.
An Intimate Life of Medical Innovation and Charity.
3.
In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.
4.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
5.
When does a melanoma metastasize? Implications for management
1.
The latest Hematocrit: An Overview of Red Blood Cell Health
2.
Glycopyrrolate: The Secret Weapon for Excessive Sweating
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape
5.
Reshaping the Battlefield Through Tumor Microenvironment Modulation for Cancer Therapy
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation